Performing quantitative assessments of serum concentrations of anti-mullerian hormone (AMH)
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201700301P
- Awardee
-
Ansh Labs, LLC UEI UKT8EX8YU8Z9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,551
Award facts
- Opportunity
-
- N02CO7256595 Solicitation number
- Analysis of Serum Anti-Mllerian Hormone (AMH) Levels in Relationship to Mammographic Density and Measures of Lobular Involution in Premenopausal Participants in the BREAST Stamp and Komen Tissue Bank Studies by using a picoAMH ELISA array. Award Notice · Posted Apr 26, 2017
- Contract value 100% obligated
- $25,551.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Webster, TX, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$77 | |
| Original award | $25,628 |
Quick answers
Who was awarded contract HHSN261201700301P?
HHSN261201700301P was awarded to Ansh Labs, LLC by National Cancer Institute (National Institutes of Health) on July 5, 2017.
How much is contract HHSN261201700301P worth?
The government has obligated $25,551 on HHSN261201700301P.
Was contract HHSN261201700301P competed?
The extent of competition for HHSN261201700301P was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award